HLN logo

Haleon plc (HLN)

Profile

Full Name

Haleon plc

Ticker

NYSE: HLN

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United Kingdom

IPO

July 25, 2022

Indexes

Not included

Website

http://www.haleon.com

Employees

24561

Key Details

Price

$9.96(-1.48%)

Market cap

Last Dividend

$0.12

TTM Dividend yield

1.70%

Annual revenue

$14.36B(+2.08% YoY)

Annual EPS

$0.40(+42.71% YoY)

PE ratio

24.76

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.96
    HLN price is $9.96

    30-Day Relative Volume

    0.70
    HLN 30-day relative volume is 0.70

    Price Performance

    Price Most recent change

    -1.48%
    HLN price was down -1.48% on Jul 11, 2025

    Price YTD change

    +4.4%
    HLN price is up +4.4% since January 1st

    Price 1-year change

    +13.18%
    HLN price is up +13.18% year-on-year

    Price 3-year change

    -
    HLN price 3-year change is unknown

    Price Range

    Price All-time high

    $11.42
    HLN price is currently -12.78% below its historical high of $11.42

    Price 3-year low

    $5.59
    HLN price is currently +78.18% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $44.74B
    HLN market capitalization is $44.74 billion

    Market cap 3-year change

    -
    HLN market capitalization 3-year change is unknown

    Market cap All-time high

    $51.34B
    HLN market capitalization is currently -12.86% below its historical high of $51.34 billion

    Market cap sector rank

    97.19%
    HLN market capitalization is higher than 97.19% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.51%
    HLN shares outstanding is down -1.51% year-on-year

    Shares Outstanding 3-Year Change

    -
    HLN shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.20
    HLN beta is 0.20

    200-day SMA

    $10.08
    HLN price is currently -1.17% below its 200-day simple moving average

    50-day SMA

    $10.68
    HLN price is currently -6.74% below its 50-day simple moving average

    RSI

    27.02
    HLN 14-day relative strength index is 27.02

    Volume

    0.70
    HLN 30-day relative volume is 0.70

    ATR

    $0.12
    HLN average true range is $0.12

    10-day Historical Volatility

    9.80%
    HLN 10-day historical volatility is 9.80%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.12
    HLN last dividend was $0.12 per share, with an ex-dividend date of April 25, 2025

    Next Dividend

    -
    HLN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.16
    HLN annual dividend per share is $0.16

    Dividend per share Sector Rank

    8.24%
    HLN annual dividend per share is higher than 8.24% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +52.51%
    HLN annual dividend per share is up +52.51% year-on-year

    Dividend per share 3-Year Change

    -
    HLN annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    1.59%
    HLN annual dividend yield is 1.59%

    Dividend yield Sector Rank

    42.86%
    HLN annual dividend yield is higher than 42.86% of companies in Healthcare sector

    Other

    Payout ratio

    39.53%
    HLN annual payout ratio is 39.53%

    Dividends paid

    $728.48M
    HLN annual dividends paid is $728.48 million

    Free cash flow

    $2.53B
    HLN annual free cash flow is $2.53 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $14.36B
    HLN annual revenue is $14.36 billion

    Revenue Analysts estimate

    $11.25B
    HLN annual revenue is currently +27.62% higher than the consensus analysts' forecast

    Revenue 1-year change

    +2.08%
    HLN annual revenue is up +2.08% year-on-year

    Revenue Sector rank

    95.3%
    HLN annual revenue is higher than 95.3% of companies in Healthcare sector

    EPS

    EPS

    $0.40
    HLN annual earnings per share is $0.40

    EPS Analysts estimate

    $0.50
    HLN annual earnings per share is currently -19.37% lower than the consensus analysts' forecast

    EPS 1-year change

    +42.71%
    HLN annual earnings per share is up +42.71% year-on-year

    EPS Sector rank

    86.36%
    HLN annual earnings per share is higher than 86.36% of companies in Healthcare sector

    Profit

    Gross profit

    $8.72B
    HLN annual gross profit is $8.72 billion

    Gross margin

    60.75%
    HLN annual gross profit margin is 60.75%

    Operating profit

    $2.82B
    HLN annual operating income is $2.82 billion

    Operating margin

    19.64%
    HLN annual operating profit margin is 19.64%

    Net income

    $1.84B
    HLN annual net profit is $1.84 billion

    Net margin

    12.84%
    HLN annual net profit margin is 12.84%

    Expenses

    Total expenses

    $11.54B
    HLN annual total expenses is $11.54 billion

    Operating expenses

    $5.90B
    HLN annual total operating expenses is $5.90 billion

    Cost of goods sold

    $5.63B
    HLN annual cost of goods sold is $5.63 billion

    Selling, general & administrative expenses

    $5.69B
    HLN annual SGA is $5.69 billion

    Depreciation and amortization

    $414.08M
    HLN annual depreciation & amortization is $414.08 million

    Interest expense

    $490.77M
    HLN annual interest expense is $490.77 million

    Income tax

    $555.95M
    HLN annual income tax is $555.95 million

    EBIT & EBITDA

    EBIT

    $2.93B
    HLN annual earnings before interest & taxes is $2.93 billion

    EBITDA

    $3.35B
    HLN annual EBITDA is $3.35 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $43.06B
    HLN annual total assets is $43.06 billion

    Non current assets

    $35.88B
    HLN annual long term assets is $35.88 billion

    Current assets

    $7.17B
    HLN annual total current assets is $7.17 billion

    Cash and cash equivalents

    $2.82B
    HLN annual cash & cash equivalents is $2.82 billion

    Accounts receivable

    $2.58B
    HLN annual accounts receivable is $2.58 billion

    Inventory

    $1.49B
    HLN annual inventory is $1.49 billion

    Liabilities

    Total liabilities

    $22.70B
    HLN annual total liabilities is $22.70 billion

    Long term liabilities

    $15.41B
    HLN annual total long term liabilities is $15.41 billion

    Current liabilities

    $7.29B
    HLN annual total current liabilities is $7.29 billion

    Accounts payable

    $4.65B
    HLN annual accounts payable is $4.65 billion

    Debt

    Total debt

    $12.71B
    HLN annual total debt is $12.71 billion

    Total debt 1-year change

    +5.49%
    HLN annual total debt is up +5.49% year-on-year

    Long term debt

    $10.84B
    HLN annual long term debt is $10.84 billion

    Short term debt

    $1.87B
    HLN annual short term debt is $1.87 billion

    Equity & Capital

    Shareholders equity

    $20.28B
    HLN annual stockholders equity is $20.28 billion

    Book value

    $20.28B
    HLN annual book value is $20.28 billion

    Retained earnings

    $34.22B
    HLN annual retained earnings is $34.22 billion

    Working capital

    -$117.95M
    HLN annual working capital is -$117.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $2.94B
    HLN annual cash flow from operations is $2.94 billion

    Cash from operations 1-year change

    +12.54%
    HLN annual cash flow from operations is up +12.54% year-on-year

    Cash from investing

    $674.80M
    HLN annual cash flow from investing activities is $674.80 million

    Cash from investing 1-year change

    +504.71%
    HLN annual cash flow from investing activities is up +504.71% year-on-year

    Cash from financing

    -$1.96B
    HLN annual cash flow from financing activities is -$1.96 billion

    Cash from financing 1-year change

    -0.68%
    HLN annual cash flow from financing activities is down -0.68% year-on-year

    CAPEX

    CAPEX

    $406.42M
    HLN annual capital expenditures is $406.42 million

    CAPEX 1-year change

    -2.79%
    HLN annual capital expenditures is down -2.79% year-on-year

    Free Cash Flow

    Free cash flow

    $2.53B
    HLN annual free cash flow is $2.53 billion

    Free cash flow 1-year change

    +15.46%
    HLN annual free cash flow is up +15.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.75%
    HLN annual gross profit margin is 60.75%

    Operating margin

    19.64%
    HLN annual operating profit margin is 19.64%

    Net margin

    12.84%
    HLN annual net profit margin is 12.84%

    ROA & ROE

    ROA

    4.26%
    HLN annual return on assets is 4.26%

    ROE

    8.85%
    HLN annual return on equity is 8.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    24.76
    HLN price to earnings ratio is 24.76

    PE ratio Sector rank

    51.64%
    HLN price to earnings ratio is higher than 51.64% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.21
    HLN price to book ratio is 2.21

    PB ratio Sector rank

    59.14%
    HLN price to book ratio is higher than 59.14% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.12
    HLN price to sales ratio is 3.12

    PS ratio Sector rank

    50.8%
    HLN price to sales ratio is higher than 50.8% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $54.66B
    HLN enterprise value is $54.66 billion

    Enterprise value Sector rank

    97.33%
    HLN enterprise value is higher than 97.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    18.63
    HLN EV/EBITDA is 18.63

    EV/EBITDA Sector rank

    90.77%
    HLN EV/EBITDA is higher than 90.77% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.98
    HLN annual current ratio is 0.98

    Quick ratio

    0.78
    HLN annual quick ratio is 0.78

    Leverage

    Debt to equity

    0.63
    HLN annual debt to equity ratio is 0.63

    Interest coverage ratio

    5.97
    HLN annual interest coverage ratio is 5.97

    Risk & Stability

    Piotroski F-Score

    -
    HLN piotroski f-score value is unknown

    Altman Z-Score

    2.85
    HLN altman z-score is 2.85

    Analyst ratings

    Recent major analysts updates

    Sep 20, 24 Morgan Stanley
    Overweight
    Mar 26, 24 Argus Research
    Buy
    Nov 1, 23 Morgan Stanley
    Overweight
    Apr 6, 23 Argus Research
    Buy
    Sep 28, 22 Argus Research
    Hold
    Jul 29, 22 Deutsche Bank
    Hold

    Institutional Ownership

    Screeners with HLN included

    UK stocks
    Stocks below SMA 200
    Stocks above SMA 50
    Healthcare sector
    All stocks
    Companies with buyback
    Ex Dividend dates calendar
    Stocks with low RSI
    NYSE Companies
    Large cap stocks
    • What is the ticker symbol for Haleon plc?
    • Does Haleon plc pay dividends?
    • What sector is Haleon plc in?
    • What industry is Haleon plc in?
    • What country is Haleon plc based in?
    • When did Haleon plc go public?
    • Is Haleon plc in the S&P 500?
    • Is Haleon plc in the NASDAQ 100?
    • Is Haleon plc in the Dow Jones?
    • When was Haleon plc's last earnings report?
    • When does Haleon plc report earnings?

    What is the ticker symbol for Haleon plc?

    The ticker symbol for Haleon plc is NYSE:HLN

    Does Haleon plc pay dividends?

    Yes, Haleon plc pays dividends. The last payment was $0.12, with an ex-dividend date on April 25, 2025

    What sector is Haleon plc in?

    Haleon plc is in the Healthcare sector

    What industry is Haleon plc in?

    Haleon plc is in the Drug Manufacturers - Specialty & Generic industry

    What country is Haleon plc based in?

    Haleon plc is headquartered in United Kingdom

    When did Haleon plc go public?

    Haleon plc's initial public offering (IPO) was on July 25, 2022

    Is Haleon plc in the S&P 500?

    No, Haleon plc is not included in the S&P 500 index

    Is Haleon plc in the NASDAQ 100?

    No, Haleon plc is not included in the NASDAQ 100 index

    Is Haleon plc in the Dow Jones?

    No, Haleon plc is not included in the Dow Jones index

    When was Haleon plc's last earnings report?

    Haleon plc's most recent earnings report was on February 27, 2025

    When does Haleon plc report earnings?

    The next expected earnings date for Haleon plc is July 31, 2025
    On this page